Ultrasound-responsive in situ antigen "nanocatchers" open a new paradigm for personalized tumor immunotherapy (IMAGE)

Chinese Chemical Society

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.